日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis

非酒精性脂肪性肝炎中体重变化和奥贝胆酸相关的临床和代谢效应

Hameed, B; Terrault, N A; Gill, R M; Loomba, R; Chalasani, N; Hoofnagle, J H; Van Natta, M L

Liver injury is associated with mortality in sickle cell disease.

肝损伤与镰状细胞病患者的死亡率相关

Feld J J, Kato G J, Koh C, Shields T, Hildesheim M, Kleiner D E, Taylor J G 6th, Sandler N G, Douek D, Haynes-Williams V, Nichols J S, Hoofnagle J H, Jake Liang T, Gladwin M T, Heller T

Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response.

低剂量和标准剂量聚乙二醇干扰素α-2a治疗慢性丙型肝炎(基因型2或3):疗效、耐受性、病毒动力学和细胞因子反应

Rotman Y, Borg B B, Soza A, Feld J J, Modi A A, Loomba R, Lutchman G, Rivera E, Doo E, Ghany M G, Heller T, Neumann A U, Liang T J, Hoofnagle J H

The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C

慢性丙型肝炎患者血清中丙型肝炎病毒RNA负链的物理状态

Shindo, M; Di Bisceglie, A M; Akatsuka, T; Fong, T L; Scaglione, L; Donets, M; Hoofnagle, J H; Feinstone, S M

Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C

检测慢性丙型肝炎患者肝脏和血清中丙型肝炎病毒RNA的复制中间体

Fong, T L; Shindo, M; Feinstone, S M; Hoofnagle, J H; Di Bisceglie, A M

Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis

原发性胆汁性肝硬化患者血清中抗补体受体活性

Minuk, G Y; Vergalla, J; Hanson, R G; Hoofnagle, J H; Frank, M M; Jones, E A

Hepatitis B core antigen: immunology and electron microscopy

乙型肝炎核心抗原:免疫学和电子显微镜

Barker, L F; Almeida, J D; Hoofnagle, J H; Gerety, R J; Jackson, D R; McGrath, P P